Figures & data
Table 1. Characteristics of included trials investigating the immunogenicity and safety of Ebola virus vaccination
Figure 2. Network graph of eligible Ebola vaccines comparisons for immunogenicity
![Figure 2. Network graph of eligible Ebola vaccines comparisons for immunogenicity](/cms/asset/b91a981d-4e01-4bf4-92af-a029551a94b9/khvi_a_1932214_f0002_b.gif)
Figure 3. Summary of risk bias assessment for RCTs Ebola vaccines comparisons
![Figure 3. Summary of risk bias assessment for RCTs Ebola vaccines comparisons](/cms/asset/e1b99f9b-0f83-4dff-9667-373ac72a8710/khvi_a_1932214_f0003_oc.jpg)
Figure 5. Pairwise comparisons in network meta-analysis for safety outcomes (injection site-pain, fatigue, headache, myalgia, and fever)
![Figure 5. Pairwise comparisons in network meta-analysis for safety outcomes (injection site-pain, fatigue, headache, myalgia, and fever)](/cms/asset/984a23b0-7420-4e17-8c9d-8175f375fb55/khvi_a_1932214_f0005_oc.jpg)
Supplemental Material
Download Zip (103.8 MB)Availability of data and materials
The data are available upon request ([email protected]).